InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Baldo Lance, Directeur Médical. Director active across 1 company, notably Adaptive Biotechnologies Corp. In total, 2 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €61k. History available since 7 March 2022. The latest transaction was filed on 8 March 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Lance Baldo is the Chief Medical Officer at Adaptive Biotechnologies Corp. He oversees the company's medical and research initiatives, ensuring that products meet quality standards. Lance plays a key role in developing new health solutions.